Suppr超能文献

淋巴细胞中的糖皮质激素受体:脑退化的一个可能标志物?

Corticosteroid receptors in lymphocytes: a possible marker of brain involution?

作者信息

Armanini D

机构信息

Istituto Semeiotica Medica, University of Padua, Chair of Endocrinology, Italy.

出版信息

J Steroid Biochem Mol Biol. 1994 Jun;49(4-6):429-34. doi: 10.1016/0960-0760(94)90289-5.

Abstract

A similarity has recently been found between the regulation of corticosteroid receptors in brain and in lymphoid tissue. We have studied the regulation of corticosteroid receptors in human mononuclear leukocytes as a possible marker of brain involution. Type I corticosteroid receptors are down regulated by excess of mineralocorticoids (primary and secondary hyperaldosteronism, pseudohyperaldosteronism) and of glucocorticoids (Cushing's syndrome). Type II corticosteroid receptors are not reduced by excess of endogenous corticosteroids (Cushing's syndrome). In normal adults there is a direct significant correlation between plasma cortisol and Type I and between plasma cortisol and Type II receptors in mononuclear leukocytes, while in Cushing's syndrome the correlation is inverse between plasma cortisol at 8 a.m. and Type II receptors. In an aged population the mean numbers of Type I and of Type II receptors are lower and plasma cortisol is higher than in adult controls, but the increase of plasma cortisol is not followed by a clinical picture of hypercorticism. Corticosteroid Type I and Type II receptors are inversely correlated with age. After dexamethasone suppression (1 mg at 11 p.m.) Type I receptors always decrease in controls while the response of Type II is not homogeneous. In an aged group of patients, both receptors are reduced by dexamethasone. We conclude that the decrease with age of corticosteroid receptors is possibly related to a physiological involution of corticosteroid receptors and that this reduction does increase plasma cortisol concentration, without affecting the glucocorticoid effector mechanism.

摘要

最近发现,大脑和淋巴组织中皮质类固醇受体的调节存在相似性。我们研究了人类单核白细胞中皮质类固醇受体的调节情况,将其作为大脑退化的一种可能标志物。I型皮质类固醇受体在盐皮质激素(原发性和继发性醛固酮增多症、假性醛固酮增多症)和糖皮质激素(库欣综合征)过量时会下调。II型皮质类固醇受体不会因内源性皮质类固醇(库欣综合征)过量而减少。在正常成年人中,血浆皮质醇与单核白细胞中的I型受体以及与II型受体之间存在直接显著相关性,而在库欣综合征中,上午8点的血浆皮质醇与II型受体之间呈负相关。在老年人群中,I型和II型受体的平均数量低于成年对照组,血浆皮质醇水平高于成年对照组,但血浆皮质醇升高并未伴随皮质醇增多的临床表现。I型和II型皮质类固醇受体与年龄呈负相关。地塞米松抑制试验(晚上11点服用1毫克)后,对照组的I型受体总是减少,而II型受体的反应并不一致。在老年患者组中,两种受体都会被地塞米松降低。我们得出结论,皮质类固醇受体随年龄增长而减少可能与皮质类固醇受体的生理性退化有关,并且这种减少确实会增加血浆皮质醇浓度,但不会影响糖皮质激素效应机制。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验